Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 26.6B | 26.7B | 25.8B | 27.5B |
Cost of revenue | 17.3B | 17.7B | 16.8B | 18.2B |
Gross profit | 9.3B | 9.0B | 9.0B | 9.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.6B | 3.0B | 2.6B | 2.7B |
Operating income | 4.1B | 3.7B | 3.9B | 3.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 881.1M | 1.0B | 983.7M | 1.0B |
Other income expense | — | — | — | — |
Pretax income | 3.5B | 3.2B | 3.0B | 3.0B |
Tax provision | 1.0B | 421.4M | 477M | 846M |
Net income | 2.4B | 2.8B | 2.5B | 2.1B |
Basic EPS | 19.3 | — | 19.9 | 16.6 |
Diluted EPS | 19.3 | — | 19.9 | 16.6 |
Basic average shares | 126.3M | — | 126.2M | 126.3M |
Diluted average shares | 126.3M | — | 126.2M | 126.3M |
EBITDA | 5.4B | 5.3B | 5.0B | 5.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -6.9M | -6.2M | -23.8M | -39.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |